FR2791142B1 - Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa - Google Patents
Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpaInfo
- Publication number
- FR2791142B1 FR2791142B1 FR9903304A FR9903304A FR2791142B1 FR 2791142 B1 FR2791142 B1 FR 2791142B1 FR 9903304 A FR9903304 A FR 9903304A FR 9903304 A FR9903304 A FR 9903304A FR 2791142 B1 FR2791142 B1 FR 2791142B1
- Authority
- FR
- France
- Prior art keywords
- brefeldine
- cpas
- presentation
- increase
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000001342 constant potential amperometry Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9903304A FR2791142B1 (fr) | 1999-03-17 | 1999-03-17 | Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa |
AU32988/00A AU3298800A (en) | 1999-03-17 | 2000-03-16 | Effect of brefeldin a on antigen-presenting cells |
EP00910959A EP1163516A1 (fr) | 1999-03-17 | 2000-03-16 | Effet de la brefeldine a sur les cellules presentatrices d'antigenes |
PCT/FR2000/000636 WO2000055622A1 (fr) | 1999-03-17 | 2000-03-16 | Effet de la brefeldine a sur les cellules presentatrices d'antigenes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9903304A FR2791142B1 (fr) | 1999-03-17 | 1999-03-17 | Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2791142A1 FR2791142A1 (fr) | 2000-09-22 |
FR2791142B1 true FR2791142B1 (fr) | 2001-06-22 |
Family
ID=9543309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9903304A Expired - Fee Related FR2791142B1 (fr) | 1999-03-17 | 1999-03-17 | Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1163516A1 (fr) |
AU (1) | AU3298800A (fr) |
FR (1) | FR2791142B1 (fr) |
WO (1) | WO2000055622A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2101177A1 (fr) * | 2008-03-10 | 2009-09-16 | Universite Joseph Fourier | Utilisation d'un peptide synthétique dérivé de la protéine zébra pour le diagnostic in vitro de la réactivation du virus d'Epstein-Barr (EBV) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474769A (en) * | 1991-03-08 | 1995-12-12 | Sterling Winthrop Inc. | Treatment of microbial infection by monocyte stimulation with interleukin-7 |
US5112607A (en) * | 1991-06-05 | 1992-05-12 | The United States Of America As Represented By The Secretary Of The Army | Potentiation of immunotoxin action by Brefeldin A |
US5254342A (en) * | 1991-09-30 | 1993-10-19 | University Of Southern California | Compositions and methods for enhanced transepithelial and transendothelial transport or active agents |
WO1994006470A1 (fr) * | 1992-09-15 | 1994-03-31 | Johnson & Johnson | Peptides immunoreactifs issus du virus d'epstein-barr |
WO1996020723A1 (fr) * | 1994-12-30 | 1996-07-11 | Brigham & Women's Hospital | Regulation de signaux induits par traf |
FR2728904B1 (fr) * | 1995-01-04 | 1997-03-14 | Pasteur Institut | Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif |
-
1999
- 1999-03-17 FR FR9903304A patent/FR2791142B1/fr not_active Expired - Fee Related
-
2000
- 2000-03-16 EP EP00910959A patent/EP1163516A1/fr not_active Withdrawn
- 2000-03-16 AU AU32988/00A patent/AU3298800A/en not_active Abandoned
- 2000-03-16 WO PCT/FR2000/000636 patent/WO2000055622A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1163516A1 (fr) | 2001-12-19 |
AU3298800A (en) | 2000-10-04 |
WO2000055622A1 (fr) | 2000-09-21 |
FR2791142A1 (fr) | 2000-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI972945A (fi) | Antigeenien antamiseen soveltuvia koostumuksia | |
MX158900A (es) | Mejoras a composicion de champu para lavar la piel | |
MX9101127A (es) | Composiciones de liberacion sostenidas para tratar enfermedad periodontal | |
NO901489D0 (no) | Anordning for aa forbinde to kanter. | |
ITMI911392A1 (it) | Meccanismo per compiere traiettorie prefissate assimilabili ad ellittiche | |
FR2737971B1 (fr) | Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee | |
IS5333A (is) | Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku | |
IT1223654B (it) | Dispositivo per l'applicazione all'estremita tagliata di un foglio per imbiallacciatura | |
FR2791142B1 (fr) | Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa | |
FR2689011B1 (fr) | Preparation phytotherapique cosmetique pour les levres. | |
IT1244638B (it) | Dispositivo per eliminare formazione di peluria. | |
FR2746495B1 (fr) | Tete militaire tandem pour l'attaque de cibles actives | |
FR2722649B1 (fr) | Machine pour gaver les palmipedes au mais entier | |
FR2623359B1 (fr) | Coutre reversible pour soc de charrue | |
FI960152A (fi) | Laipio laivan kannen sulkemiseksi | |
BR9604898A (pt) | Bomba para transportar uma polpa úmida | |
IT8221386V0 (it) | Dispositivo associabile al corpo di una tazza igienica per consentire a quest'ultima di fungere da bidet. | |
IT1274542B (it) | Dispositivo per impostare la priorita' di una presa elettrica | |
ES531546A0 (es) | Una instalacion para facilitar el subsiguiente descortezado de troncos por friccion | |
ITMI930463A1 (it) | Macchina per conformare la parte posteriore delle scarpe | |
IT1114312B (it) | Dispositivo per impedire la formazione di gernggli parassiti lungo il fusto di una vite | |
ITBO950604A1 (it) | Dispositivo per calzature, utilizzabile in particolare per prevenire la formazione di cariche elettrostatiche | |
KR970012183U (ko) | 원심력에 변형되는 공 | |
BR9501482A (pt) | Bomba para tomar mate | |
ES1002255Y (es) | Dispositivo para aumentar la altura de una bandeja-contenedor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |